1-20 of 39
James M. Reuben
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3635: TBK1 inhibition potentiates the efficacy of AXL-targeted therapy by modulating tumor microenvironment in aggressive breast cancers

Lan Phi, Takashi Semba, Ngu V. Trinh, Fang Zou, Jason M. Foulks, Steven L. Warner, Savitri Krishnamurthy, James P. Long, James M. Reuben, Debu Tripathy, Naoto T. Ueno, Xiaoping Wang
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3635.
https://doi.org/10.1158/1538-7445.AM2023-3635
Published: 04 April 2023
View article titled, Abstract 3635: TBK1 inhibition potentiates the efficacy of AXL-targeted therapy by modulating tumor microenvironment in aggressive breast cancers
Journal Articles

Abstract PD10-08: Remodeling the inflammatory breast cancer tumor microenvironment to enhance immunotherapy: Novel therapeutic development

Xiaoping Wang, Takashi Semba, Ganiraju C. Manyam, Jing Wang, Shan Shao, Francois Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan ThiHanh Phi, Troy Pearson, Jared K. Burks, Evan N. Cohen, James M. Reuben, Fei Yang, Hu Min, Nicholas Navin, Toshiaki Iwase, Yichao Shen, Xiang Zhang, Debu Tripathy, Naoto T. Ueno
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PD10-08.
https://doi.org/10.1158/1538-7445.SABCS21-PD10-08
Published: 15 February 2022
View article titled, Abstract PD10-08: Remodeling the inflammatory breast cancer tumor microenvironment to enhance immunotherapy: Novel therapeutic development
Journal Articles

Abstract 5067: Suppression of tumorigenicity and metastasis of triple-negative breast cancer (TNBC) by c-Jun N-Terminal Kinase (JNK) inhibitor via reversing immunosuppressive tumor microenvironment (TME)

Takashi Semba, Xuemei Xie, Evan N. Cohen, James M. Reuben, Kevin N. Dalby, Xiaoping Wang, Naoto T. Ueno
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 5067.
https://doi.org/10.1158/1538-7445.AM2020-5067
Published: 15 August 2020
View article titled, Abstract 5067: Suppression of tumorigenicity and metastasis of triple-negative breast cancer (TNBC) by c-Jun N-Terminal Kinase (JNK) inhibitor via reversing immunosuppressive tumor microenvironment (TME)
Journal Articles

Abstract P3-09-12: Peripheral T cell clonality and exhaustion as novel biomarkers for anti-PD-1 (pembrolizumab) maintenance therapy in patients with metastatic inflammatory breast cancer (mIBC) and non-IBC triple negative breast cancer (mTNBC)

Hui Gao, Kumiko Kida, Evan N Cohen, Angela Alexander, Bora Lim, Charla Parker, Sanda Tin, Vicente Valero, Debu Tripathy, Alexandre Reuben, Naoto T Ueno, James M Reuben
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P3-09-12.
https://doi.org/10.1158/1538-7445.SABCS19-P3-09-12
Published: 15 February 2020
View article titled, Abstract P3-09-12: Peripheral T cell clonality and exhaustion as novel biomarkers for anti-PD-1 (pembrolizumab) maintenance therapy in patients with metastatic inflammatory breast cancer (mIBC) and non-IBC triple negative breast cancer (mTNBC)
Journal Articles

Abstract OT1-02-02: A pilot study to examine the feasibility of measuring CTC and inflammatory biomarker changes resulting from atorvastatin as adjuvant therapy in TNBC and TN-IBC patients with residual disease after neoadjuvant chemotherapy

Angela Alexander, Takeo Fujii, Michael C Stauder, Wendy A Woodward, James M Reuben, Yu Shen, Diane Liu, Sangeetha M Reddy, Vicente Valero, Susan C Gilchrist, Bora Lim, Anthony Lucci, Naoto T Ueno, Carlos H Barcenas
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): OT1-02-02.
https://doi.org/10.1158/1538-7445.SABCS19-OT1-02-02
Published: 15 February 2020
View article titled, Abstract OT1-02-02: A pilot study to examine the feasibility of measuring CTC and inflammatory biomarker changes resulting from atorvastatin as adjuvant therapy in TNBC and TN-IBC patients with residual disease after neoadjuvant chemotherapy
Journal Articles

Abstract 564: Identification of biomarkers predictive of response to panitumumab combined with neoadjuvant chemotherapy for primary inflammatory breast cancer

Xiaoping Wang, Naoko Matsuda, Bora Lim, Savitri Krishnamurthy, Juhee Song, Yu Shen, Wenhui Wu, Jianhua Hu, Wendy A. Woodward, James M. Reuben, Anthony Lucci, Debu Tripathy, Vicente Valero, Naoto T. Ueno
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 564.
https://doi.org/10.1158/1538-7445.AM2018-564
Published: 01 July 2018
View article titled, Abstract 564: Identification of biomarkers predictive of response to panitumumab combined with neoadjuvant chemotherapy for primary inflammatory breast cancer
Journal Articles

Abstract 897: PEA-15 regulates epithelial-mesenchymal transition and invasive behavior through its phosphorylation in triple-negative breast cancer

Jihyun Park, Evan N. Cohen, Gaurav Chauhan, Jangsoon Lee, Naoto T. Ueno, Debu Tripathy, James M. Reuben, Chandra Bartholomeusz
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 897.
https://doi.org/10.1158/1538-7445.AM2017-897
Published: 01 July 2017
View article titled, Abstract 897: PEA-15 regulates epithelial-mesenchymal transition and invasive behavior through its phosphorylation in triple-negative breast cancer
Journal Articles

Abstract CT057: A single-arm, preoperative, pilot study to evaluate the safety and biological effects of orally administered reparixin in early breast cancer patients who are candidates for surgery

Lori J. Goldstein, Raymond P. Perez, Denise A. Yardley, Linda K. Han, James M. Reuben, Susan McCanna, Beth Butler, Pier Adelchi Ruffini, Jenny C. Chang
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): CT057.
https://doi.org/10.1158/1538-7445.AM2016-CT057
Published: 15 July 2016
View article titled, Abstract CT057: A single-arm, preoperative, pilot study to evaluate the safety and biological effects of orally administered reparixin in early breast cancer patients who are candidates for surgery
Journal Articles

Abstract 496: Androgen receptor expression on circulating tumor cells in metastatic breast cancer

Takeo Fujii, Yipeng Wang, James M. Reuben, Rachel Krupa, Ryon Graf, Lyndsey Dugan, Jessica Kouw, Dena Marrinucci, Bora Lim, Carlos H. Barcenas, Angela N. Marx, Debu Tripathy, Ryan Dittamore, Naoto T. Ueno
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 496.
https://doi.org/10.1158/1538-7445.AM2016-496
Published: 15 July 2016
View article titled, Abstract 496: Androgen receptor expression on circulating tumor cells in metastatic breast cancer
Journal Articles

Abstract 651: Male mouse model of canine and human inflammatory breast cancer (IBC)

Sara Caceres, Laura Peña, Maria J. Illera, Gema Silvan, Paloma J. de andres, Hui Gao, Wendy A. Woodward, James M. Reuben, Juan C. Illera
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 651.
https://doi.org/10.1158/1538-7445.AM2016-651
Published: 15 July 2016
View article titled, Abstract 651: Male mouse model of canine and human inflammatory breast cancer (IBC)
Journal Articles

Abstract 4990: Sequential tracking of PD-L1 expression and RAD50 induction in CTCs and circulating stromal cells of lung cancer patients during treatment with radiotherapy

Daniel L. Adams, Martin J. Edelman, Penny Fang, Wen Jiang, Jianzhong He, Ting Xu, Hui Gao, James M. Reuben, Yawei Qiao, Steven Hahn, Ritsuko Komaki, Zhongxing Liao, Cha-Mei Tang, Steven H. Lin
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4990.
https://doi.org/10.1158/1538-7445.AM2016-4990
Published: 15 July 2016
View article titled, Abstract 4990: Sequential tracking of PD-L1 expression and RAD50 induction in CTCs and circulating stromal cells of lung cancer patients during treatment with radiotherapy
Journal Articles

Abstract 5295: Latent class longitudinal modeling of CTCs in ER+ metastatic breast cancer patients

Terry Hyslop, Xuechan Li, Rui Duan, Mario Giuliano, Antonio Giordano, Marlana Orloff, Hallgeir Rui, James M. Reuben, Massimo Cristofanilli
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 5295.
https://doi.org/10.1158/1538-7445.AM2015-5295
Published: 01 August 2015
View article titled, Abstract 5295: Latent class longitudinal modeling of CTCs in ER+ metastatic breast cancer patients
Journal Articles

Abstract P6-14-07: High miR-19a serum levels correlate with favorable prognosis in patients with metastatic HER2+ inflammatory breast cancer and may result from an effective antibody-dependent cell-mediated cytotoxicity induced by trastuzumab

Simone Anfossi, Antonio Giordano, Lei Huo, Ricardo H Alvarez, Vicente Valero, Gabriel N Hortobagyi, Wendy A Woodward, Naoto T Ueno, George A Calin, James M Reuben
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P6-14-07.
https://doi.org/10.1158/1538-7445.SABCS14-P6-14-07
Published: 01 May 2015
View article titled, Abstract P6-14-07: High miR-19a serum levels correlate with favorable prognosis in patients with metastatic HER2<sup>+</sup> inflammatory breast cancer and may result from an effective antibody-dependent cell-mediated cytotoxicity induced by trastuzumab
Journal Articles

Abstract P6-16-01: The microRNA miR-141 is a key regulator of brain metastasis from breast cancer

Bisrat G Debeb, Lara Lacerda, Simone Anfossi, Parmeswaran Diagaradjane, Khoi Chu, Lei Huo, Caimiao Wei, Richard A Larson, Adam R Wolfe, Wei Xu, Daniel L Smith, Li Li, Cristina Ivan, Pamela K Allen, Xiang H Zhang, George A Calin, Savitri Krishnamurthy, Naoto T Ueno, Thomas A Buchholz, James M Reuben, Wendy A Woodward
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P6-16-01.
https://doi.org/10.1158/1538-7445.SABCS14-P6-16-01
Published: 01 May 2015
View article titled, Abstract P6-16-01: The microRNA miR-141 is a key regulator of brain metastasis from breast cancer
Journal Articles

Abstract P6-03-01: A phase Ib study of the CXCR1/2 inhibitor reparixin in combination with weekly paclitaxel in metastatic HER2 negative breast cancer – First analysis

Anne F Schott, Max S Wicha, Raymond P Perez, Giraldo Kato, Tiffany Avery, Massimo Cristofanilli, James M Reuben, R Katherine Alpaugh, Susan McCanna, Pier Adelchi Ruffini, Lori J Goldstein
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P6-03-01.
https://doi.org/10.1158/1538-7445.SABCS14-P6-03-01
Published: 01 May 2015
View article titled, Abstract P6-03-01: A phase Ib study of the CXCR1/2 inhibitor reparixin in combination with weekly paclitaxel in metastatic HER2 negative breast cancer – First analysis
Journal Articles

Abstract P4-01-04: Circulating tumor cells (CTC) are associated with defects in innate and adaptive immunity in inflammatory breast cancer (IBC) patients

Michal Mego, Hui Gao, Evan N Cohen, Simone Anfossi, Antonio Giordano, Sanda Tin, Tamer M Fouad, Wendy A Woodward, Ricardo H Alvarez, Vicente Valero, Naoto T Ueno, Gabriel N Hortobagyi, Massimo Cristofanilli, James M Reuben
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P4-01-04.
https://doi.org/10.1158/1538-7445.SABCS14-P4-01-04
Published: 01 May 2015
View article titled, Abstract P4-01-04: Circulating tumor cells (CTC) are associated with defects in innate and adaptive immunity in inflammatory breast cancer (IBC) patients
Journal Articles

Abstract P4-01-10: Predictive impact of circulating tumor cells with an epithelial-to-mesenchymal transition phenotype in patients with primary breast cancer treated with primary systemic therapy

Fanny Le Du, Dzifa Y Duose, Elisha J Dettman, Jackson A Summer, Mariana Chavez-MacGregor, Carlos H Barcenas, Abenaa M Brewster, Alvarez H Ricardo, Vincente Valero, Ana M Gonzalez-Angulo, James M Reuben, Naoto T Ueno
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P4-01-10.
https://doi.org/10.1158/1538-7445.SABCS14-P4-01-10
Published: 01 May 2015
View article titled, Abstract P4-01-10: Predictive impact of circulating tumor cells with an epithelial-to-mesenchymal transition phenotype in patients with primary breast cancer treated with primary systemic therapy
Journal Articles

Abstract P4-04-09: Mesenchymal stem cells and macrophage interactions promote inflammatory breast cancer cell invasion and self renewal

Adam R Wolfe, Rachel Atkinson, Bisrat G Debeb, Yan Zhang, Brian Ruffel, James M Reuben, Naoto T Ueno, Wendy A Woodward
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P4-04-09.
https://doi.org/10.1158/1538-7445.SABCS14-P4-04-09
Published: 01 May 2015
View article titled, Abstract P4-04-09: Mesenchymal stem cells and macrophage interactions promote inflammatory breast cancer cell invasion and self renewal
Journal Articles

Abstract P5-04-05: Co-stimulation through 4-1BB/CD137 improves expansion and function of tumor-infiltrating T lymphocytes from primary and metastatic triple-negative breast cancer and inflammatory breast cancer

Michiko Harao, Hui Gao, Jie Qing Chen, Elizabeth A Mittendorf, Gildy V Babiera, Sarah M DeSnyder, Korrene F Rockwood, Savitri Krishnamurthy, Huiming Sun, Jie S Willey, Naoto T Ueno, James M Reuben, Laszlo G Radvanyi
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P5-04-05.
https://doi.org/10.1158/1538-7445.SABCS14-P5-04-05
Published: 01 May 2015
View article titled, Abstract P5-04-05: Co-stimulation through 4-1BB/CD137 improves expansion and function of tumor-infiltrating T lymphocytes from primary and metastatic triple-negative breast cancer and inflammatory breast cancer
Journal Articles

Abstract P5-07-04: Characterization of a new canine inflammatory mammary cancer (IMC) cell line (IPC-366)

Sara Caceres, Laura Peña, Lara C Alvarez de la Cerda, Maria J Illera, Richard Larson, Hui Gao, Bisrat G Debeb, Wendy A Woodward, James M Reuben, Juan C Illera
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P5-07-04.
https://doi.org/10.1158/1538-7445.SABCS14-P5-07-04
Published: 01 May 2015
View article titled, Abstract P5-07-04: Characterization of a new canine inflammatory mammary cancer (IMC) cell line (IPC-366)